By , LONDON/CHICAGO (Reuters) - Coordinators of a global coronavirus vaccines funding scheme are looking at a wide range of potential prices for COVID-19 shots, with a reported $40 per dose price tag the “highest number” in that range, one of the co-leads of the project said on Monday.Seth Berkley, chief executive of the GAVI vaccine alliance, which is co-leading the COVAX facility designed to ensure fair global access to COVID-19 shots, said the facility had no specific target price and would also seek to negotiate tiered pricing for richer and poorer countries.Berkley rejected comments...…By , LONDON/CHICAGO (Reuters) - Coordinators of a global coronavirus vaccines funding scheme are looking at a wide range of potential prices for COVID-19 shots, with a reported $40 per dose price tag the “highest number” in that range, one of the co-leads of the project said on Monday.Seth Berkley, chief executive of the GAVI vaccine alliance, which is co-leading the COVAX facility designed to ensure fair global access to COVID-19 shots, said the facility had no specific target price and would also seek to negotiate tiered pricing for richer and poorer countries.Berkley rejected comments...WW…

By , LONDON/CHICAGO (Reuters) - AstraZeneca will publish up-to-date results from its major U.S. COVID-19 vaccine trial within 48 hours after health officials publicly criticized the drugmaker for using “outdated information” to show how well the immunization worked.The rare public rebuke marks the latest setback for the vaccine once hailed as a milestone in the fight against the COVID-19 pandemic that has since been dogged by questions over its effectiveness and possible side effects.AstraZeneca said results it published on Monday in which the vaccine had demonstrated 79% efficacy were...…By , LONDON/CHICAGO (Reuters) - AstraZeneca will publish up-to-date results from its major U.S. COVID-19 vaccine trial within 48 hours after health officials publicly criticized the drugmaker for using “outdated information” to show how well the immunization worked.The rare public rebuke marks the latest setback for the vaccine once hailed as a milestone in the fight against the COVID-19 pandemic that has since been dogged by questions over its effectiveness and possible side effects.AstraZeneca said results it published on Monday in which the vaccine had demonstrated 79% efficacy were...WW…

Register now for FREE unlimited access to Reuters.comCHICAGO, April 15 (Reuters) - Anthony Fauci, the top U.S. infectious disease doctor, hopes U.S. regulators will make a quick decision to lift a pause on the Johnson & Johnson vaccine and get that vaccine “back on track,” he said in an interview with Reuters on Thursday.His comments come a day after a panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) delayed a vote on whether to resume the J&J shots for at least a week, until it had more data on the risk.The United States earlier this week decided to...…Register now for FREE unlimited access to Reuters.comCHICAGO, April 15 (Reuters) - Anthony Fauci, the top U.S. infectious disease doctor, hopes U.S. regulators will make a quick decision to lift a pause on the Johnson & Johnson vaccine and get that vaccine “back on track,” he said in an interview with Reuters on Thursday.His comments come a day after a panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) delayed a vote on whether to resume the J&J shots for at least a week, until it had more data on the risk.The United States earlier this week decided to...WW…

By CHICAGO (Reuters) - The United States may not need AstraZeneca’s COVID-19 vaccine, even if it wins U.S. regulatory approval, Anthony Fauci, the nation’s top infectious disease doctor told Reuters on Thursday.The vaccine, once hailed as another milestone in the fight against the COVID-19 pandemic, has been dogged by questions since late last year, even as it has been authorized for use by dozens of countries, not including United States.Fauci, director of the National Institute of Allergy and Infectious Diseases and chief medical adviser to the White House, said the United States has...…By CHICAGO (Reuters) - The United States may not need AstraZeneca’s COVID-19 vaccine, even if it wins U.S. regulatory approval, Anthony Fauci, the nation’s top infectious disease doctor told Reuters on Thursday.The vaccine, once hailed as another milestone in the fight against the COVID-19 pandemic, has been dogged by questions since late last year, even as it has been authorized for use by dozens of countries, not including United States.Fauci, director of the National Institute of Allergy and Infectious Diseases and chief medical adviser to the White House, said the United States has...WW…

By (This March 30 story corrects last paragraph to show the paper has been peer reviewed)CHICAGO (Reuters) - A critical component of the immune system known as T cells that respond to fight infection from the original version of the novel coronavirus appear to also protect against three of the most concerning new virus variants, according to a U.S. laboratory study released on Tuesday.Several recent studies have shown that certain variants of the novel coronavirus can undermine immune protection from antibodies and vaccines.But antibodies - which block the coronavirus from attaching to...…By (This March 30 story corrects last paragraph to show the paper has been peer reviewed)CHICAGO (Reuters) - A critical component of the immune system known as T cells that respond to fight infection from the original version of the novel coronavirus appear to also protect against three of the most concerning new virus variants, according to a U.S. laboratory study released on Tuesday.Several recent studies have shown that certain variants of the novel coronavirus can undermine immune protection from antibodies and vaccines.But antibodies - which block the coronavirus from attaching to...WW…

By (Reuters) - The U.S. government on Saturday authorized Johnson & Johnson’s single-dose COVID-19 vaccine, enabling millions more Americans to be vaccinated in the coming weeks and setting the vaccine up for additional approvals around the world.The J&J vaccine is the third authorized in the United States, following ones from Pfizer/BioNTech and Moderna, both of which require two doses.The U.S. Food and Drug Administration announced the emergency use authorization of the J&J vaccine for adults aged 18 and older following Friday’s unanimous endorsement by the agency’s panel of...…By (Reuters) - The U.S. government on Saturday authorized Johnson & Johnson’s single-dose COVID-19 vaccine, enabling millions more Americans to be vaccinated in the coming weeks and setting the vaccine up for additional approvals around the world.The J&J vaccine is the third authorized in the United States, following ones from Pfizer/BioNTech and Moderna, both of which require two doses.The U.S. Food and Drug Administration announced the emergency use authorization of the J&J vaccine for adults aged 18 and older following Friday’s unanimous endorsement by the agency’s panel of...WW…

By CHICAGO (Reuters) - Clinical trial data on two COVID-19 vaccines show that a coronavirus variant first identified in South Africa is lessening their ability to protect against the illness, underscoring the need to vaccinate vast numbers of people as quickly as possible, scientists said.The vaccines from Novavax Inc and Johnson & Johnson were welcomed as important future weapons in curbing deaths and hospitalizations in a pandemic that has infected more than 101 million people and claimed over 2 million lives worldwide.But they were significantly less effective at preventing COVID-19...…By CHICAGO (Reuters) - Clinical trial data on two COVID-19 vaccines show that a coronavirus variant first identified in South Africa is lessening their ability to protect against the illness, underscoring the need to vaccinate vast numbers of people as quickly as possible, scientists said.The vaccines from Novavax Inc and Johnson & Johnson were welcomed as important future weapons in curbing deaths and hospitalizations in a pandemic that has infected more than 101 million people and claimed over 2 million lives worldwide.But they were significantly less effective at preventing COVID-19...WW…

By , WASHINGTON (Reuters) - The U.S. Food and Drug Administration’s chief had a “robust discussion” with the White House this week about the timeline for coronavirus vaccine approvals and believes vaccinating 20 million Americans this year is realistic, he said on Friday.FDA Commissioner Stephen Hahn declined to lay out a specific timetable for approval of the vaccine developed by Pfizer and BioNTech but said he hoped the regulator would make a decision this month.Many federal officials are expecting a vaccine approval within days of a Dec. 10 meeting of experts, though one FDA official...…By , WASHINGTON (Reuters) - The U.S. Food and Drug Administration’s chief had a “robust discussion” with the White House this week about the timeline for coronavirus vaccine approvals and believes vaccinating 20 million Americans this year is realistic, he said on Friday.FDA Commissioner Stephen Hahn declined to lay out a specific timetable for approval of the vaccine developed by Pfizer and BioNTech but said he hoped the regulator would make a decision this month.Many federal officials are expecting a vaccine approval within days of a Dec. 10 meeting of experts, though one FDA official...WW…

By CHICAGO (Reuters) - Dr. Anthony Fauci, the top U.S. infectious disease expert, said he has had no contact with President-elect Joe Biden’s coronavirus transition team and sees no reason to quit to join that effort when there is so much to do now to fight the surging pandemic.“I stay in my lane. I’m not a politician. I do public health things,” he said in an interview on Thursday ahead of next week’s Reuters Total Health conference.Since January, Fauci has served on President Donald Trump’s White House Coronavirus Task Force, a position that has frequently put him at odds with the...…By CHICAGO (Reuters) - Dr. Anthony Fauci, the top U.S. infectious disease expert, said he has had no contact with President-elect Joe Biden’s coronavirus transition team and sees no reason to quit to join that effort when there is so much to do now to fight the surging pandemic.“I stay in my lane. I’m not a politician. I do public health things,” he said in an interview on Thursday ahead of next week’s Reuters Total Health conference.Since January, Fauci has served on President Donald Trump’s White House Coronavirus Task Force, a position that has frequently put him at odds with the...WW…